Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-19

FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' supplemental application for pregabalin (generic pregabalin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)